Every woman with a bleeding disorder knows about doubt, writes columnist. But it's important to keep speaking out.

Data from a primate study suggested MGX-001 has potential as a hemophilia A treatment, moving the drug closer to clinical ...

Jennifer Lynne is an entrepreneur specializing in digital marketing, a self-professed computer nerd, and a nationally competitive Scrabble player. Jennifer has strong ties to the bleeding disorder ...

Hemlibra (emicizumab-kxwh) safely supports joint health in children with hemophilia A without inhibitors through three years ...

Columnist Jennifer Lynne talks to Connie Montgomery, who has factor VII deficiency, about her advocacy for women with bleeding disorders.

MacDonald reflects on how much hemophilia care has changed and reminds her how much she has to be thankful for.

Many women with hemophilia grew up being taught to downplay their symptoms, writes columnist. That is the wrong approach.

Caregiving cuts both ways, writes columnist Allyx Formalejo this Family Caregivers Month, and not all care flows in the ...

Taking charge of your health when you have hemophilia is of great importance. Regardless of your hemophilia type — A, B or C — the goal is to keep your joints strong and healthy, and to keep extra ...

Geneventiv Therapeutics said it had a “positive and constructive” meeting with the U.S. Food and Drug Administration (FDA) on its plan to develop GENV-HEM, a gene therapy for hemophilia A. The meeting ...

The energy in the room was unmistakable. Before the official start of the Hope Conference in Orlando, Florida, last week, a group of women had been invited for a special preconference event — a day ...

Geneventiv Therapeutics said it had a “positive and constructive” meeting with the U.S. Food and Drug Administration (FDA) on its plan to develop GENV-HEM, a gene therapy for hemophilia A. The meeting ...